Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from social media, news, blogs, forums, messengers, enterprise data, and the dark Web, creating predictive analytics. Cyber Security is a deep analytics platform that captures, structures, and visualizes vast amounts of unstructured social media data, which is used as a discovery tool that allows organizations to make decisions. It offers Nexa Products, which consists of NexaSecurity and NexaSMART. Healthcare consists of Imagine Health Centres, a multidisciplinary healthcare facility, and Medi-Call, a telehealth platform. The Company also offers a mobile blockchain game, Cereal Crunch.


TSXV:DM - Post by User

Comment by Investor10Xon Nov 19, 2021 5:51pm
397 Views
Post# 34148212

RE:RE:RE:3rd quarter

RE:RE:RE:3rd quarter
frm10328 wrote: Agreed, 100%


swyint123888 wrote: 17 million is high for Q3 according to the guidance they gave and the comment Marshall made about Q3 being light

Guidance suggest 25 to 30 million second half of 2021 and Q3 is light according to the boss

I'm thinking more like 7-9 million Q3 and 18-21 million Q4.....not too shabby no matter how you slice it

 




Q3 could possibly be in the range of $10-15 million. This would contine to put the company on pace for a $60 million run rate for the year, which is absolutely incredible for a micro/small cap company.  This alone is a reason as to why this company should take off.  It's one of the few stocks on the venture with a positive EPS.  That EPS could possibly double. 

Keep in mind that the quarter will be compared to last year's 3rd quarter and regardless of the lull that people are mentioning for the covid testing in the summer, Q3 this year should blow away Q3 of last year.  Yes, there was a small bit of downtime in the movie industry over the summer, but DM also added 3-4 more productions over the summer to that list of tests.  I believe DM is testing for 30 productions in total, this is up from the previous quarter.  That should make up a bit of that difference for that lull. 

The testing for the cruise line entertainment section did not commence until the end of Q3 on September 30th.  As they did commence testing on September 30th there may be a few numbers from that testing added to the Q3 financials. 

The company wrote down a lot of their legacy assets last quarter, so that their books would be "squeaky clean", as a clean balance sheet is what institutions look for.   This tends to come before revenue and DM probably gets an A+ on both of those (i.e. clean books and revenue).

In the end, MG does not control the direction of the stock, but sooner or later the stock pice will begin to reflect the balance sheet, revenue, growing contracts, growth and expansion of the verticals and the direction of the company.  I have invested in a number of stocks over the years that went sideways for a long time before running up.  As always, patience is needed.  Zenyetta (ZEN - now Zentek) took many years before is shot up.  But those who held were very well rewarded.  

Q4 on the other hand, could possibly be in that $20 million + range.  All that takes DM to that $60 million run rate I mentioned in August.  So why am I invested in this stock....  need I really say more.
<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse